Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 29

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 29
---
 we received feedback on matters such as our classified board structure, plurality voting for director elections, and supermajority voting requirements for certain changes to our governance documents. The following summarizes highlights of that feedback.

| Topic                                                                      |     | What We Heard                                                                                                                                                                                                                                                                |
| Classified board structure                                                 |     | While most expressed a preference for annual director elections, we also heard from some stockholders that a classified board makes sense under certain circumstances.                                                                                                       |
| Plurality voting for director elections                                    |     | There was a general preference expressed for a majority standard for uncontested director elections, or, in the alternative, for the addition of a director resignation policy applicable to a director who fails to receive a majority of votes in an uncontested election. |
| Supermajority voting standards for certain changes to governance documents |     | There was a general preference expressed for a simple majority standard, except in circumstances where the provision provides protections for minority stockholders if a substantial or dominant stockholder exists.                                                         |

| Inspire Medical Systems, Inc. |     | 24 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

| CORPORATE GOVERNANCE |

BOARD CONSIDERATION AND RESPONSIVENESS The Board reviewed the feedback from stockholders and discussed the perspectives shared as well as trends in market practices. After extensive consideration, the Board determined to provide additional disclosure on the rationale for the current governance structure (which disclosure is provided in the “Corporate Governance” section of this Proxy Statement). The Board will continue to regularly revisit and evaluate the Company’s governance practices and potential modifications and consider any stockholder feedback to ensure that the structure is appropriate for the Company’s circumstances and stage of growth and in the best interests of the Company and its stockholders.

| Inspire Medical Systems, Inc. |     | 25 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

Director Compensation Non-Employee Director Compensation Policy We maintain a compensation policy that provides cash and equity compensation to our non-employee directors for their service on the Board and its committees as discussed below. On a periodic basis, the Organization and Compensation Committee reviews the policy to ensure that the level of compensation is appropriate to attract and retain a diverse group of directors with the breadth of experience necessary to perform our Board’s duties and to compensate our directors fairly for their services, and to determine whether any recommendations for adjustment should be made to the Board. The review includes the consideration of qualitative and comparative factors. To ensure directors are compensated relative to the scope of their responsibilities, the